Emerging therapies are reshaping schizophrenia care by introducing novel mechanisms that extend beyond traditional dopamine receptor blockade. Listen in to learn from Dr Leslie Citrome about evolving concepts in schizophrenia neurobiology; the clinical evidence supporting emerging therapeutic approaches with a focus on muscarinic-targeted therapies; and practical strategies for translating these advances into patient care, including treatment selection, safety, and tolerability considerations.

Presenter:
Leslie Citrome, MD, MPH
Clinical Professor, Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, New York
Adjunct Professor, Psychiatry and Behavioral Sciences
Northwestern Feinberg School of Medicine
Chicago, Illinois

Link to full program:
https://bit.ly/4gvLZYm

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Neuroscience Podcast on Apple Podcasts, YouTube Music, or Spotify.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Decera Clinical Education. Innehållet i podden är skapat av Decera Clinical Education och inte av, eller tillsammans med, Poddtoppen.